Compile Data Set for Download or QSAR
Report error Found 1790 Enz. Inhib. hit(s) with Target = 'Insulin receptor'
TargetInsulin receptor(Human)
University of Melbourne

Curated by ChEMBL
LigandPNGBDBM50459972(CHEMBL4226003)
Affinity DataKd:  0.0200nMAssay Description:Displacement of [TyrA14-125I]-human insulin from human insulin receptor isoform A expressed in baby hamster kidney cells after 2 days by gamma counti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details Article
PubMed
TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184545(US9150578, I-172)
Affinity DataIC50: 0.0500nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184383(US9150578, I-031)
Affinity DataIC50: 0.0500nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184387(US9150578, I-035)
Affinity DataIC50: 0.0800nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184548(US9150578, I-174)
Affinity DataIC50: 0.0800nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184520(US9150578, I-149)
Affinity DataIC50: 0.0800nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184544(US9150578, I-171)
Affinity DataIC50: 0.0800nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184486(US9150578, I-119)
Affinity DataIC50: 0.0900nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184543(US9150578, I-170)
Affinity DataIC50: 0.0900nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184480(US9150578, I-113)
Affinity DataIC50: 0.0900nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184382(US9150578, I-030)
Affinity DataIC50: 0.100nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184542(US9150578, I-173 | US9150578, I-169)
Affinity DataIC50: 0.100nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184440(US9150578, I-074)
Affinity DataIC50: 0.100nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184485(US9150578, I-118)
Affinity DataIC50: 0.100nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184357(US9150578, I-005)
Affinity DataIC50: 0.100nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184483(US9150578, I-116)
Affinity DataIC50: 0.110nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184482(US9150578, I-115)
Affinity DataIC50: 0.110nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184373(US9150578, I-021)
Affinity DataIC50: 0.120nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184425(US9150578, I-059)
Affinity DataIC50: 0.130nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184428(US9150578, I-062)
Affinity DataIC50: 0.130nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184505(US9150578, I-134)
Affinity DataIC50: 0.130nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184507(US9150578, I-136)
Affinity DataIC50: 0.130nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184484(US9150578, I-117)
Affinity DataIC50: 0.130nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184481(US9150578, I-114)
Affinity DataIC50: 0.130nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184521(US9150578, I-150)
Affinity DataIC50: 0.140nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184504(US9150578, I-133)
Affinity DataIC50: 0.140nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184506(US9150578, I-135)
Affinity DataIC50: 0.140nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184532(US9150578, I-161)
Affinity DataIC50: 0.140nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184427(US9150578, I-061)
Affinity DataIC50: 0.150nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184526(US9150578, I-155)
Affinity DataIC50: 0.150nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184519(US9150578, I-148)
Affinity DataIC50: 0.150nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184356(US9150578, I-004)
Affinity DataIC50: 0.160nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184530(US9150578, I-159)
Affinity DataIC50: 0.160nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184549(US9150578, I-175)
Affinity DataIC50: 0.160nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184367(US9150578, I-015)
Affinity DataIC50: 0.160nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184429(US9150578, I-063)
Affinity DataIC50: 0.160nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184500(US9150578, I-129)
Affinity DataIC50: 0.160nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184376(US9150578, I-024)
Affinity DataIC50: 0.160nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184447(US9150578, I-081)
Affinity DataIC50: 0.160nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184518(US9150578, I-147)
Affinity DataIC50: 0.160nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184386(US9150578, I-034)
Affinity DataIC50: 0.170nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184381(US9150578, I-029)
Affinity DataIC50: 0.170nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184374(US9150578, I-022)
Affinity DataIC50: 0.170nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184517(US9150578, I-146)
Affinity DataIC50: 0.170nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184502(US9150578, I-131)
Affinity DataIC50: 0.170nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184424(US9150578, I-058)
Affinity DataIC50: 0.180nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184501(US9150578, I-130)
Affinity DataIC50: 0.180nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184420(US9150578, I-054)
Affinity DataIC50: 0.190nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184535(US9150578, I-164)
Affinity DataIC50: 0.190nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetInsulin receptor [964-1370](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM184542(US9150578, I-173 | US9150578, I-169)
Affinity DataIC50: 0.200nMpH: 7.4Assay Description:The kinase activity is measured by DELFIA assay (dissociation-enhanced lanthanide fluorescence immunoassay, Perkin Elmer). The cytoplasmic kinase dom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

Displayed 1 to 50 (of 1790 total ) | Next | Last >>
Jump to: